Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study

Malaria Journal

Table 7 Perinatal and neonatal mortality, and morbidity during the first month of life by treatment (%)

	AL		ASAQ		MQAS		DHAPQ		p-value^a
	N	Value^b	N	Value^b	N	Value^b	N	Value^b	p-value^a
Perinatal mortality	837	15 (17.9)	789	14 (17.7)	787	22 (28.0)	784	19 (24.2)	0.77
Neonatal mortality	822	16 (19.5)	775	20 (25.8)	765	10 (13.1)	765	24 (31.4)	0.21
Morbidity
Fever (4–6 week)	764	37 (48.4)	718	34 (47.4)	715	42 (58.7)	680	23 (33.8)	0.82
Diarrhoea (4–6 week)	764	14 (18.3)	717	22 (30.7)	715	19 (26.6)	679	4 (5.9)	0.62
Cough (4–6 week)	764	34 (44.5)	717	33 (46.0)	715	56 (78.3)	679	52 (76.6)	0.02
Difficulty in feeding (4–6 week)	764	2 (2.6)	717	5 (7.0)	715	6 (8.4)	679	1 (1.5)	0.76
Jaundice (4–6 weeks)	764	0 (0.0)	717	1 (1.4)	714	2 (2.8)	679	1 (1.5)	0.90
Other symptoms (4–6 week)	764	33 (43.2)	717	44 (61.4)	715	51 (71.3)	679	16 (23.6)	0.33

^ap-values are from logistic regression adjusted for country
^bvalues are n (/1000 live births) except perinatal mortality which has n (/1000 total births)

ISSN: 1475-2875